Publication:
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.

dc.contributor.authorBaniandrés-Rodríguez, Ofelia
dc.contributor.authorVilar-Alejo, Jaime
dc.contributor.authorRivera, Raquel
dc.contributor.authorCarrascosa, José Manuel
dc.contributor.authorDaudén, Esteban
dc.contributor.authorHerrera-Acosta, Enrique
dc.contributor.authorSahuquillo-Torralba, Antonio
dc.contributor.authorGómez-García, Fran J
dc.contributor.authorNieto-Benito, Lula María
dc.contributor.authorde la Cueva, Pablo
dc.contributor.authorLópez-Estebaranz, José Luis
dc.contributor.authorBelinchón, Isabel
dc.contributor.authorFerrán Farrés, Marta
dc.contributor.authorAlsina, Mercè
dc.contributor.authorFernández-Freire, Lourdes Rodríguez
dc.contributor.authorCarretero, Gregorio
dc.contributor.authorGarcía-Donoso, Carmen
dc.contributor.authorBallescá, Ferrán
dc.contributor.authorLlamas-Velasco, Mar
dc.contributor.authorHerrera-Ceballos, Enrique
dc.contributor.authorBotella-Estrada, Rafael
dc.contributor.authorRuiz-Genao, Diana Patricia
dc.contributor.authorRiera-Monroig, Josep
dc.contributor.authorDescalzo Gallego, Miguel Ángel
dc.contributor.authorGarcía-Doval, Ignacio
dc.contributor.authorBIOBADADERM Study Group
dc.date.accessioned2023-02-09T09:45:35Z
dc.date.available2023-02-09T09:45:35Z
dc.date.issued2020-10-26
dc.identifier.doi10.1016/j.jaad.2020.10.046
dc.identifier.essn1097-6787
dc.identifier.pmcPMC7587130
dc.identifier.pmid33122022
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587130/pdf
dc.identifier.unpaywallURLhttp://www.jaad.org/article/S0190962220328589/pdf
dc.identifier.urihttp://hdl.handle.net/10668/16501
dc.issue.number2
dc.journal.titleJournal of the American Academy of Dermatology
dc.journal.titleabbreviationJ Am Acad Dermatol
dc.language.isoen
dc.organizationHospital Universitario Reina Sofía
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number513-517
dc.pubmedtypeLetter
dc.rights.accessRightsopen access
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshCOVID-19
dc.subject.meshCohort Studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshIncidence
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPsoriasis
dc.subject.meshRegistries
dc.subject.meshSeverity of Illness Index
dc.subject.meshSpain
dc.titleIncidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number84
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7587130.pdf
Size:
223.43 KB
Format:
Adobe Portable Document Format